Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gabin Kenfack
Treatment of Viral Hepatitis C by the Sofosbuvir and Ledipasvir With or Without Ribavirin Combination in Cameroon: Efficiency, Tolerance and Significant Predictors of SVR12
Clinical Infection and Immunity
Related publications
Kidney Transplant Recipients With Hepatitis C Virus Experienced 100% SVR12 Rate When Treated With Sofosbuvir-Ledipasvir
Hepatology
Medicine
Hepatology
Efficacy and Safety of Ribavirin With Sofosbuvir Plus Ledipasvir in Patients With Genotype 1 Hepatitis C: A Meta-Analysis
Digestive Diseases and Sciences
Physiology
Gastroenterology
Sofosbuvir Plus Daclatasvir With or Without Ribavirin in 551 Patients With Hepatitis C-Related Cirrhosis, Genotype 4
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Ledipasvir and Sofosbuvir for Recurrent Hepatitis C After Liver Transplantation
BioScience Trends
Biochemistry
Health
Medicine
Genetics
Molecular Biology
Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection
JAMA - Journal of the American Medical Association
Medicine
Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in Treatment-Naïve Hepatitis C Virus Genotype 1-Infected Patients Without Cirrhosis Treated With a Simeprevir/Sofosbuvir/Ledipasvir Regimen
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Sofosbuvir-Velpatasvir-Voxilaprevir With or Without Ribavirin in Direct-Acting Antiviral-Experienced Patients With Genotype 1 Hepatitis C Virus
Hepatology
Medicine
Hepatology
Sofosbuvir and Ledipasvir in Attainment of SVR12 in Sickle Cell Disease (SCD) Sub-Population With Chronic Hepatitis C (CHC). A Single Center Prospective Study-Slash C Trial
HPB
Hepatology
Gastroenterology
